Vitamin a and retinoid signaling: Genomic and nongenomic effects

Journal of Lipid Research

Volumn 54, Issue 7, 2013, Pages 1761-1775

  Al Tanoury, Ziad ^a   Piskunov, Aleksandr ^a   Rochette Egly, Cećile ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Kinase cascade; Nuclear receptor; Retinoic acid receptor; Retinoid X receptor; Transcription

Indexed keywords

11 CIS RETINAL; CELL NUCLEUS RECEPTOR; COREPRESSOR PROTEIN; DNA; FATTY ACID BINDING PROTEIN; HETERODIMER; HISTONE H3; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR; RETINOL; S6 KINASE;

CYTOSOL; ENZYME ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENOME ANALYSIS; INTRACELLULAR SIGNALING; LIGAND BINDING; METABOLITE; MOLECULAR INTERACTION; NERVE CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN POLYMORPHISM; RECEPTOR BINDING; REVIEW; SERTOLI CELL; TRANSCRIPTION REGULATION; VISION; VITAMIN METABOLISM;

KINASE CASCADE; NUCLEAR RECEPTOR; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; TRANSCRIPTION;

ANIMALS; GENOMICS; HUMANS; RETINOIDS; SIGNAL TRANSDUCTION; VITAMIN A;

EID: 84878977179     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R030833     Document Type: Review

References (169)

1. Harrison, E. H. 2012. Mechanisms involved in the intestinal absorption of dietary vitamin A and provitamin A carotenoids. Biochim. Biophys. Acta. 1821: 70-77.
2. Clagett-Dame, M., and H. F. DeLuca. 2002. The role of vitamin A in mammalian reproduction and embryonic development. Annu. Rev. Nutr. 22: 347-381. (Pubitemid 35229924)
3. Clagett-Dame, M., and D. Knutson. 2011. Vitamin A in reproduction and development. Nutrients. 3: 385-428.
4. Altucci, L., and H. Gronemeyer. 2001. The promise of retinoids to fight against cancer. Nat. Rev. Cancer. 1: 181-193. (Pubitemid 33741893)
5. McKenna, N. J. 2012. EMBO retinoids 2011: mechanisms, biology and pathology of signaling by retinoic acid and retinoic acid receptors. Nucl. Recept. Signal. 10: e003.
6. Mark, M., N. B. Ghyselinck, and P. Chambon. 2009. Function of retinoic acid receptors during embryonic development. Nucl. Recept. Signal. 7: e002.
7. Curley, R. W., Jr. 2012. Retinoid chemistry: synthesis and application for metabolic disease. Biochim. Biophys. Acta. 1821: 3-9.
8. Kusakabe, T. G., N. Takimoto, M. Jin, and M. Tsuda. 2009. Evolution and the origin of the visual retinoid cycle in vertebrates. Philos. Trans. R. Soc. Lond. B Biol. Sci. 364: 2897-2910.
9. nd edition. Raven Press, New York.
10. Heyman, R. A., D. J. Mangelsdorf, J. A. Dyck, R. B. Stein, G. Eichele, R. M. Evans, and C. Thaller. 1992. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell. 68: 397-406.
11. Levin, A. A., L. J. Sturzenbecker, S. Kazmer, T. Bosakowski, C. Huselton, G. Allenby, J. Speck, C. Kratzeisen, M. Rosenberger, A. Lovey, et al. 1992. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha. Nature. 355: 359-361.
12. Wolf, G. 2006. Is 9-cis-retinoic acid the endogenous ligand for the retinoic acid-X receptor? Nutr. Rev. 64: 532-538. (Pubitemid 46057720)
13. Calléja, C., N. Messaddeq, B. Chapellier, H. Yang, W. Krezel, M. Li, D. Metzger, B. Mascrez, K. Ohta, H. Kagechika, et al. 2006. Genetic and pharmacological evidence that a retinoic acid cannot be the RXR-activating ligand in mouse epidermis keratinocytes. Genes Dev. 20: 1525-1538. (Pubitemid 43830658)
14. Germain, P., P. Chambon, G. Eichele, R. M. Evans, M. A. Lazar, M. Leid, A. R. De Lera, R. Lotan, D. J. Mangelsdorf, and H. Gronemeyer. 2006. International Union of Pharmacology. LXIII. Retinoid X receptors. Pharmacol. Rev. 58: 760-772. (Pubitemid 44833744)
15. Kane, M. A., A. E. Folias, A. Pingitore, M. Perri, K. M. Obrochta, C. R. Krois, E. Cione, J. Y. Ryu, and J. L. Napoli. 2010. Identification of 9-cis-retinoic acid as a pancreas-specific autacoid that attenuates glucose-stimulated insulin secretion. Proc. Natl. Acad. Sci. USA. 107: 21884-21889.
16. Pérez, E., W. Bourguet, H. Gronemeyer, and A. R. de Lera. 2012. Modulation of RXR function through ligand design. Biochim. Biophys. Acta. 1821: 57-69.
17. Budhu, A. S., and N. Noy. 2002. Direct channeling of retinoic acid between cellular retinoic acid-binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest. Mol. Cell. Biol. 22: 2632-2641. (Pubitemid 34262985)
18. Delva, L., J. N. Bastie, C. Rochette-Egly, R. Kraiba, N. Balitrand, G. Despouy, P. Chambon, and C. Chomienne. 1999. Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex. Mol. Cell. Biol. 19: 7158-7167. (Pubitemid 29441896)
19. Dong, D., S. E. Ruuska, D. J. Levinthal, and N. Noy. 1999. Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid. J. Biol. Chem. 274: 23695-23698.
20. Tan, N. S., N. S. Shaw, N. Vinckenbosch, P. Liu, R. Yasmin, B. Desvergne, W. Wahli, and N. Noy. 2002. Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol. Cell. Biol. 22: 5114-5127. (Pubitemid 34700702)
21. Schug, T. T., D. C. Berry, N. S. Shaw, S. N. Travis, and N. Noy. 2007. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell. 129: 723-733. (Pubitemid 46802374)
22. Schug, T. T., D. C. Berry, I. A. Toshkov, L. Cheng, A. Y. Nikitin, and N. Noy. 2008. Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR. Proc. Natl. Acad. Sci. USA. 105: 7546-7551. (Pubitemid 351830055)
23. Berry, D. C., and N. Noy. 2007. Is PPARbeta/delta a retinoid receptor? PPAR Res. 2007: 73256.
24. Germain, P., P. Chambon, G. Eichele, R. M. Evans, M. A. Lazar, M. Leid, A. R. De Lera, R. Lotan, D. J. Mangelsdorf, and H. Gronemeyer. 2006. International Union of Pharmacology. LX. Retinoic acid receptors. Pharmacol. Rev. 58: 712-725. (Pubitemid 44833741)
25. Germain, P., B. Staels, C. Dacquet, M. Spedding, and V. Laudet. 2006. Overview of nomenclature of nuclear receptors. Pharmacol. Rev. 58: 685-704. (Pubitemid 44833739)
26. Bastien, J., and C. Rochette-Egly. 2004. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene. 328: 1-16. (Pubitemid 38352876)
27. Chambon, P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J. 10: 940-954. (Pubitemid 26285969)
28. Laudet, V., and H. Gronemeyer, editors. 2002. The Nuclear Receptor FactsBook. Academic Press, London.
29. Rochette-Egly, C., and P. Germain. 2009. Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors. Nucl. Recept. Signal. 7: e005.
30. Bourguet, W., M. Ruff, P. Chambon, H. Gronemeyer, and D. Moras. 1995. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature. 375: 377-382.
31. Renaud, J. P., N. Rochel, M. Ruff, V. Vivat, P. Chambon, H. Gronemeyer, and D. Moras. 1995. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature. 378: 681-689.
32. Bourguet, W., P. Germain, and H. Gronemeyer. 2000. Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. Trends Pharmacol. Sci. 21: 381-388.
33. Bourguet, W., V. Vivat, J. M. Wurtz, P. Chambon, H. Gronemeyer, and D. Moras. 2000. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol. Cell. 5: 289-298. (Pubitemid 30628087)
34. Glass, C. K., and M. G. Rosenfeld. 2000. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14: 121-141. (Pubitemid 30070977)
35. Rosenfeld, M. G., V. V. Lunyak, and C. K. Glass. 2006. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 20: 1405-1428. (Pubitemid 43830648)
36. Bour, G., E. Gaillard, N. Bruck, S. Lalevée, J. L. Plassat, D. Busso, J. P. Samama, and C. Rochette-Egly. 2005. Cyclin H binding to the RARalpha activation function (AF)-2 domain directs phosphorylation of the AF-1 domain by cyclin-dependent kinase 7. Proc. Natl. Acad. Sci. USA. 102: 16608-16613. (Pubitemid 41688824)
37. Lee, M. S., S. A. Kliewer, J. Provencal, P. E. Wright, and R. M. Evans. 1993. Structure of the retinoid X receptor alpha DNA binding domain: a helix required for homodimeric DNA binding. Science. 260: 1117-1121. (Pubitemid 23186785)
38. Zechel, C., X. Q. Shen, P. Chambon, and H. Gronemeyer. 1994. Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements. EMBO J. 13: 1414-1424. (Pubitemid 24090223)
39. Zechel, C., X. Q. Shen, J. Y. Chen, Z. P. Chen, P. Chambon, and H. Gronemeyer. 1994. The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats. EMBO J. 13: 1425-1433. (Pubitemid 24090224)
40. Lavery, D. N., and I. J. McEwan. 2005. Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations. Biochem. J. 391: 449-464. (Pubitemid 41634771)
41. Wärnmark, A., E. Treuter, A. P. Wright, and J. A. Gustafsson. 2003. Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation. Mol. Endocrinol. 17: 1901-1909. (Pubitemid 37287610)
42. Liu, J., N. B. Perumal, C. J. Oldfield, E. W. Su, V. N. Uversky, and A. K. Dunker. 2006. Intrinsic disorder in transcription factors. Biochemistry. 45: 6873-6888. (Pubitemid 43856673)
43. Dyson, H. J., and P. E. Wright. 2005. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 6: 197-208. (Pubitemid 40314921)
44. Samarut, E., I. Amal, G. Markov, R. Stote, A. Dejaegere, V. Laudet, and C. Rochette-Egly. 2011. Evolution of nuclear retinoic acid receptors alpha (RARa) phosphorylation sites. Serine gain provides fine-tuned regulation. Mol. Biol. Evol. 28: 2125-2137.
45. Hihi, A. K., L. Michalik, and W. Wahli. 2002. PPARs: transcriptional effectors of fatty acids and their derivatives. Cell. Mol. Life Sci. 59: 790-798. (Pubitemid 34628240)
46. Chandra, V., P. Huang, Y. Hamuro, S. Raghuram, Y. Wang, T. P. Burris, and F. Rastinejad. 2008. Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA. Nature. 456: 350-356.
47. Xu, H. E., M. H. Lambert, V. G. Montana, D. J. Parks, S. G. Blanchard, P. J. Brown, D. D. Sternbach, J. M. Lehmann, G. B. Wisely, T. M. Willson, et al. 1999. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol. Cell. 3: 397-403. (Pubitemid 29290680)
48. Berry, D. C., and N. Noy. 2009. All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation- activated receptor beta/delta and retinoic acid receptor. Mol. Cell. Biol. 29: 3286-3296.
49. Stehlin-Gaon, C., D. Willmann, D. Zeyer, S. Sanglier, A. Van Dorsselaer, J. P. Renaud, D. Moras, and R. Schule. 2003. All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR beta. Nat. Struct. Biol. 10: 820-825. (Pubitemid 37187653)
50. Kruse, S. W., K. Suino-Powell, X. E. Zhou, J. E. Kretschman, R. Reynolds, C. Vonrhein, Y. Xu, L. Wang, S. Y. Tsai, M. J. Tsai, et al. 2008. Identification of COUP-TFII orphan nuclear receptor as a retinoic acid-activated receptor. PLoS Biol. 6: e227.
51. Zhou, X. E., K. M. Suino-Powell, Y. Xu, C. W. Chan, O. Tanabe, S. W. Kruse, R. Reynolds, J. D. Engel, and H. E. Xu. 2011. The orphan nuclear receptor TR4 is a vitamin A-activated nuclear receptor. J. Biol. Chem. 286: 2877-2885.
52. Lefebvre, P., P. J. Martin, S. Flajollet, S. Dedieu, X. Billaut, and B. Lefebvre. 2005. Transcriptional activities of retinoic acid receptors. Vitam. Horm. 70: 199-264. (Pubitemid 43589019)
53. Westin, S., M. G. Rosenfeld, and C. K. Glass. 2000. Nuclear receptor coactivators. Adv. Pharmacol. 47: 89-112.
54. Privalsky, M. L. 2004. The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu. Rev. Physiol. 66: 315-360. (Pubitemid 40614447)
55. Perissi, V., L. M. Staszewski, E. M. McInerney, R. Kurokawa, A. Krones, D. W. Rose, M. H. Lambert, M. V. Milburn, C. K. Glass, and M. G. Rosenfeld. 1999. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev. 13: 3198-3208. (Pubitemid 30030442)
56. le Maire, A., C. Teyssier, C. Erb, M. Grimaldi, S. Alvarez, A. R. de Lera, P. Balaguer, H. Gronemeyer, C. A. Royer, P. Germain, et al. 2010. A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor. Nat. Struct. Mol. Biol. 17: 801-807.
57. Farboud, B., and M. L. Privalsky. 2004. Retinoic acid receptor-alpha is stabilized in a repressive state by its C-terminal, isotypespecific F domain. Mol. Endocrinol. 18: 2839-2853. (Pubitemid 39577910)
58. Ghosh, J. C., X. Yang, A. Zhang, M. H. Lambert, H. Li, H. E. Xu, and J. D. Chen. 2002. Interactions that determine the assembly of a retinoid X receptor/corepressor complex. Proc. Natl. Acad. Sci. USA. 99: 5842-5847. (Pubitemid 34493227)
59. Mengeling, B. J., M. L. Goodson, W. Bourguet, and M. L. Privalsky. 2012. SMRTepsilon, a corepressor variant, interacts with a restricted subset of nuclear receptors, including the retinoic acid receptors alpha and beta. Mol. Cell. Endocrinol. 351: 306-316.
60. Farboud, B., H. Hauksdottir, Y. Wu, and M. L. Privalsky. 2003. Isotype-restricted corepressor recruitment: a constitutively closed helix 12 conformation in retinoic acid receptors beta and gamma interferes with corepressor recruitment and prevents transcriptional repression. Mol. Cell. Biol. 23: 2844-2858. (Pubitemid 36403082)
61. Hauksdottir, H., B. Farboud, and M. L. Privalsky. 2003. Retinoic acid receptors beta and gamma do not repress, but instead activate target gene transcription in both the absence and presence of hormone ligand. Mol. Endocrinol. 17: 373-385. (Pubitemid 36315632)
62. Hu, X., Y. Chen, M. Farooqui, M. C. Thomas, C. M. Chiang, and L. N. Wei. 2004. Suppressive effect of receptor-interacting protein 140 on coregulator binding to retinoic acid receptor complexes, histone-modifying enzyme activity, and gene activation. J. Biol. Chem. 279: 319-325. (Pubitemid 38044830)
63. Epping, M. T., L. Wang, M. J. Edel, L. Carlee, M. Hernandez, and R. Bernards. 2005. The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling. Cell. 122: 835-847. (Pubitemid 41345202)
64. Le Douarin, B., C. Zechel, J. M. Garnier, Y. Lutz, L. Tora, P. Pierrat, D. Heery, H. Gronemeyer, P. Chambon, and R. Losson. 1995. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 14: 2020-2033.
65. vom Baur, E., C. Zechel, D. Heery, M. J. Heine, J. M. Garnier, V. Vivat, B. Le Douarin, H. Gronemeyer, P. Chambon, and R. Losson. 1996. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 15: 110-124. (Pubitemid 26020394)
66. Despouy, G., J. N. Bastie, S. Deshaies, N. Balitrand, A. Mazharian, C. Rochette-Egly, C. Chomienne, and L. Delva. 2003. Cyclin D3 is a cofactor of retinoic acid receptors, modulating their activity in the presence of cellular retinoic acid-binding protein II. J. Biol. Chem. 278: 6355-6362. (Pubitemid 36800894)
67. Vucetic, Z., Z. Zhang, J. Zhao, F. Wang, K. J. Soprano, and D. R. Soprano. 2008. Acinus-S' represses RAR-regulated gene expression through interaction with the B-domain of RARs. Mol. Cell. Biol. 28: 2549-2558. (Pubitemid 351542356)
68. Zhao, J., Z. Zhang, Z. Vucetic, K. J. Soprano, and D. R. Soprano. 2009. HACE1: a novel repressor of RAR transcriptional activity. J. Cell. Biochem. 107: 482-493.
69. Macias, M. J., S. Wiesner, and M. Sudol. 2002. WW and SH3 domains, two different scaffolds to recognize proline-rich ligands. FEBS Lett. 513: 30-37. (Pubitemid 34242975)
70. Kay, B. K., M. P. Williamson, and M. Sudol. 2000. The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J. 14: 231-241. (Pubitemid 30086060)
71. Zarrinpar, A., and W. A. Lim. 2000. Converging on proline: the mechanism of WW domain peptide recognition. Nat. Struct. Biol. 7: 611-613. (Pubitemid 30636665)
72. Brondani, V., Q. Schefer, F. Hamy, and T. Klimkait. 2005. The peptidyl-prolyl isomerase Pin1 regulates phospho-Ser77 retinoic acid receptor alpha stability. Biochem. Biophys. Res. Commun. 328: 6-13. (Pubitemid 40164627)
73. Giannì, M., A. Boldetti, V. Guarnaccia, A. Rambaldi, E. Parrella, I. Raska, Jr., C. Rochette-Egly, G. Del Sal, A. Rustighi, M. Terao, et al. 2009. Inhibition of the peptidyl-prolyl-isomerase Pin1 enhances the responses of acute myeloid leukemia cells to retinoic acid via stabilization of RARalpha and PML-RARalpha. Cancer Res. 69: 1016-1026.
74. Bour, G., J. L. Plassat, A. Bauer, S. Lalevée, and C. Rochette-Egly. 2005. Vinexin beta interacts with the non-phosphorylated AF-1 domain of retinoid receptor gamma (RARγ) and represses RARγ-mediated transcription. J. Biol. Chem. 280: 17027-17037. (Pubitemid 41389165)
75. Lalevée, S., G. Bour, M. Quinternet, E. Samarut, P. Kessler, M. Vitorino, N. Bruck, M. A. Delsuc, J. L. Vonesch, B. Kieffer, et al. 2010. Vinexinss, an atypical "sensor" of retinoic acid receptor gamma signaling: union and sequestration, separation, and phosphorylation. FASEB J. 24: 4523-4534.
76. Balmer, J. E., and R. Blomhoff. 2005. A robust characterization of retinoic acid response elements based on a comparison of sites in three species. J. Steroid Biochem. Mol. Biol. 96: 347-354. (Pubitemid 41384136)
77. Germain, P., L. Altucci, W. Bourguet, C. Rochette-Egly, and H. Gronemeyer. 2003. Nuclear receptor superfamily: principles of signaling. Pure Appl. Chem. 75: 1619-1664.
78. Lalevée, S., Y. N. Anno, A. Chatagnon, E. Samarut, O. Poch, V. Laudet, G. Benoit, O. Lecompte, and C. Rochette-Egly. 2011. Genome-wide in silico identification of new conserved and functional retinoic acid receptor response elements (direct repeats separated by 5 bp). J. Biol. Chem. 286: 33322-33334.
79. Delacroix, L., E. Moutier, G. Altobelli, S. Legras, O. Poch, M. A. Choukrallah, I. Bertin, B. Jost, and I. Davidson. 2010. Cell-specific interaction of retinoic acid receptors with target genes in mouse embryonic fibroblasts and embryonic stem cells. Mol. Cell. Biol. 30: 231-244.
80. Mahony, S., E. O. Mazzoni, S. McCuine, R. A. Young, H. Wichterle, and D. K. Gifford. 2011. Ligand-dependent dynamics of retinoic acid receptor binding during early neurogenesis. Genome Biol. 12: R2.
81. Moutier, E., T. Ye, M. A. Choukrallah, S. Urban, J. Osz, A. Chatagnon, L. Delacroix, D. Langer, N. Rochel, D. Moras, et al. 2012. Retinoic acid receptors recognise the mouse genome through binding elements with diverse spacing and topology. J. Biol. Chem. 287: 26328-26341.
82. Mendoza-Parra, M. A., M. Walia, M. Sankar, and H. Gronemeyer. 2011. Dissecting the retinoid-induced differentiation of F9 embryonal stem cells by integrative genomics. Mol. Syst. Biol. 7: 538.
83. Kurokawa, R., J. DiRenzo, M. Boehm, J. Sugarman, B. Gloss, M. G. Rosenfeld, R. A. Heyman, and C. K. Glass. 1994. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature. 371: 528-531. (Pubitemid 24306612)
84. Leid, M., P. Kastner, and P. Chambon. 1992. Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem. Sci. 17: 427-433.
85. Khorasanizadeh, S., and F. Rastinejad. 2001. Nuclear-receptor interactions on DNA-response elements. Trends Biochem. Sci. 26: 384-390. (Pubitemid 32530657)
86. Rastinejad, F., T. Wagner, Q. Zhao, and S. Khorasanizadeh. 2000. Structure of the RXR-RAR DNA-binding complex on the retinoic acid response element DR1. EMBO J. 19: 1045-1054. (Pubitemid 30119829)
87. Brélivet, Y., N. Rochel, and D. Moras. 2012. Structural analysis of nuclear receptors: from isolated domains to integral proteins. Mol. Cell. Endocrinol. 348: 466-473.
88. Rochel, N., F. Ciesielski, J. Godet, E. Moman, M. Roessle, C. Peluso-Iltis, M. Moulin, M. Haertlein, P. Callow, Y. Mely, et al. 2011. Common architecture of nuclear receptor heterodimers on DNA direct repeat elements with different spacings. Nat. Struct. Mol. Biol. 18: 564-570.
89. Dilworth, F. J., and P. Chambon. 2001. Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription. Oncogene. 20: 3047-3054. (Pubitemid 32553559)
90. Perissi, V., K. Jepsen, C. K. Glass, and M. G. Rosenfeld. 2010. Deconstructing repression: evolving models of co-repressor action. Nat. Rev. Genet. 11: 109-123.
91. Perissi, V., A. Aggarwal, C. K. Glass, D. W. Rose, and M. G. Rosenfeld. 2004. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell. 116: 511-526. (Pubitemid 38264429)
92. Gillespie, R. F., and L. J. Gudas. 2007. Retinoic acid receptor isotype specificity in F9 teratocarcinoma stem cells results from the differential recruitment of coregulators to retinoic response elements. J. Biol. Chem. 282: 33421-33434. (Pubitemid 350159505)
93. Gillespie, R. F., and L. J. Gudas. 2007. Retinoid regulated association of transcriptional co-regulators and the polycomb group protein SUZ12 with the retinoic acid response elements of Hoxa1, RARbeta(2), and Cyp26A1 in F9 embryonal carcinoma cells. J. Mol. Biol. 372: 298-316. (Pubitemid 47267961)
94. Hou, Z., H. Peng, D. E. White, D. G. Negorev, G. G. Maul, Y. Feng, G. D. Longmore, S. Waxman, A. Zelent, and F. J. Rauscher 3rd. 2010. LIM protein Ajuba functions as a nuclear receptor corepressor and negatively regulates retinoic acid signaling. Proc. Natl. Acad. Sci. USA. 107: 2938-2943.
95. Biddie, S. C., S. John, and G. L. Hager. 2010. Genome-wide mechanisms of nuclear receptor action. Trends Endocrinol. Metab. 21: 3-9.
96. Bruck, N., D. Vitoux, C. Ferry, V. Duong, A. Bauer, H. de The, and C. Rochette-Egly. 2009. A coordinated phosphorylation cascade initiated by p38MAPK/MSK1 directs RARalpha to target promoters. EMBO J. 28: 34-47.
97. Osz, J., Y. Brelivet, C. Peluso-Iltis, V. Cura, S. Eiler, M. Ruff, W. Bourguet, N. Rochel, and D. Moras. 2012. Structural basis for a molecular allosteric control mechanism of cofactor binding to nuclear receptors. Proc. Natl. Acad. Sci. USA. 109: E588-E594.
98. Leid, M., P. Kastner, R. Lyons, H. Nakshatri, M. Saunders, T. Zacharewski, J. Y. Chen, A. Staub, J. M. Garnier, S. Mader, et al. 1992. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell. 68: 377-395.
99. Germain, P., J. Iyer, C. Zechel, and H. Gronemeyer. 2002. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature. 415: 187-192. (Pubitemid 34059522)
100. Sims 3rd, R. J., and D. Reinberg. 2008. Is there a code embedded in proteins that is based on post-translational modifications? Nat. Rev. Mol. Cell Biol. 9: 815-820.
101. Pavri, R., B. Lewis, T. K. Kim, F. J. Dilworth, H. Erdjument- Bromage, P. Tempst, G. de Murcia, R. Evans, P. Chambon, and D. Reinberg. 2005. PARP-1 determines specificity in a retinoid signaling pathway via direct modulation of mediator. Mol. Cell. 18: 83-96. (Pubitemid 40444650)
102. Le May, N., I. Iltis, J. Amé, A. Zhovner, D. Biard, J. M. Egly, V. Schreiber, and F. Coin. 2012. Poly (ADP-ribose) glycohydrolase regulates retinoic acid receptor-mediated gene expression. Mol. Cell. 48: 785-798.
103. Le May, N., D. Mota-Fernandes, R. Velez-Cruz, I. Iltis, D. Biard, and J. M. Egly. 2010. NER factors are recruited to active promoters and facilitate chromatin modification for transcription in the absence of exogenous genotoxic attack. Mol. Cell. 38: 54-66.
104. Huang, S., J. Laoukili, M. T. Epping, J. Koster, M. Holzel, B. A. Westerman, W. Nijkamp, A. Hata, S. Asgharzadeh, R. C. Seeger, et al. 2009. ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome. Cancer Cell. 15: 328-340.
105. Hua, S., R. Kittler, and K. P. White. 2009. Genomic antagonism between retinoic acid and estrogen signaling in breast cancer. Cell. 137: 1259-1271.
106. Ross-Innes, C. S., R. Stark, K. A. Holmes, D. Schmidt, C. Spyrou, R. Russell, C. E. Massie, S. L. Vowler, M. Eldridge, and J. S. Carroll. 2010. Cooperative interaction between retinoic acid receptoralpha and estrogen receptor in breast cancer. Genes Dev. 24: 171-182.
107. Schoenfelder, S., T. Sexton, L. Chakalova, N. F. Cope, A. Horton, S. Andrews, S. Kurukuti, J. A. Mitchell, D. Umlauf, D. S. Dimitrova, et al. 2010. Preferential associations between co-regulated genes reveal a transcriptional interactome in erythroid cells. Nat. Genet. 42: 53-61.
108. Wei, L. N., X. Hu, D. Chandra, E. Seto, and M. Farooqui. 2000. Receptor-interacting protein 140 directly recruits histone deacetylases for gene silencing. J. Biol. Chem. 275: 40782-40787. (Pubitemid 32054897)
109. Khetchoumian, K., M. Teletin, J. Tisserand, M. Mark, B. Herquel, M. Ignat, J. Zucman-Rossi, F. Cammas, T. Lerouge, C. Thibault, et al. 2007. Loss of Trim24 (Tif1alpha) gene function confers oncogenic activity to retinoic acid receptor alpha. Nat. Genet. 39: 1500-1506. (Pubitemid 350191338)
110. Kopf, E., J. L. Plassat, V. Vivat, H. de The, P. Chambon, and C. Rochette-Egly. 2000. Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin-proteasome pathway. J. Biol. Chem. 275: 33280-33288.
111. Giannì, M., A. Bauer, E. Garattini, P. Chambon, and C. Rochette-Egly. 2002. Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-indced RARγ degradation and transactivation. EMBO J. 21: 3760-3769. (Pubitemid 34787049)
112. Ferry, C., M. Giannì, S. Lalevée, N. Bruck, J. L. Plassat, I. Raska, Jr., E. Garattini, and C. Rochette-Egly. 2009. SUG-1 plays proteolytic and non-proteolytic roles in the control of retinoic acid target genes via its interaction with SRC-3. J. Biol. Chem. 284: 8127-8135.
113. Tansey, W. P. 2001. Transcriptional activation: risky business. Genes Dev. 15: 1045-1050. (Pubitemid 32417296)
114. Alsayed, Y., S. Uddin, N. Mahmud, F. Lekmine, D. V. Kalvakolanu, S. Minucci, G. Bokoch, and L. C. Platanias. 2001. Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid. J. Biol. Chem. 276: 4012-4019.
115. Piskunov, A., and C. Rochette-Egly. 2012. A retinoic acid receptor RARalpha pool present in membrane lipid rafts forms complexes with G protein alphaQ to activate p38MAPK. Oncogene. 31: 3333-3345.
116. Gupta, P., P. C. Ho, M. M. Huq, S. G. Ha, S. W. Park, A. A. Khan, N. P. Tsai, and L. N. Wei. 2008. Retinoic acid-stimulated sequential phosphorylation, PML recruitment, and SUMOylation of nuclear receptor TR2 to suppress Oct4 expression. Proc. Natl. Acad. Sci. USA. 105: 11424-11429.
117. Dey, N., P. K. De, M. Wang, H. Zhang, E. A. Dobrota, K. A. Robertson, and D. L. Durden. 2007. CSK controls retinoic acid receptor (RAR) signaling: a RAR-c-SRC signaling axis is required for neuritogenic differentiation. Mol. Cell. Biol. 27: 4179-4197. (Pubitemid 47018068)
118. Bost, F., L. Caron, I. Marchetti, C. Dani, Y. Le Marchand-Brustel, and B. Binetruy. 2002. Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage. Biochem. J. 361: 621-627. (Pubitemid 34177831)
119. Stavridis, M. P., B. J. Collins, and K. G. Storey. 2010. Retinoic acid orchestrates fibroblast growth factor signalling to drive embryonic stem cell differentiation. Development. 137: 881-890.
120. Cheung, Y. T., W. K. Lau, M. S. Yu, C. S. Lai, S. C. Yeung, K. F. So, and R. C. Chang. 2009. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology. 30: 127-135.
121. Masiá, S., S. Alvarez, A. R. de Lera, and D. Barettino. 2007. Rapid, nongenomic actions of retinoic Acid on phosphatidylinositol-3-kinase signaling pathway mediated by the retinoic Acid receptor. Mol. Endocrinol. 21: 2391-2402. (Pubitemid 47529353)
122. Pellegrini, M., D. Filipponi, M. Gori, F. Barrios, F. Lolicato, P. Grimaldi, P. Rossi, E. A. Jannini, R. Geremia, and S. Dolci. 2008. ATRA and KL promote differentiation toward the meiotic program of male germ cells. Cell Cycle. 7: 3878-3888.
123. Pan, J., Y. L. Kao, S. Joshi, S. Jeetendran, D. Dipette, and U. S. Singh. 2005. Activation of Rac1 by phosphatidylinositol 3-kinase in vivo: role in activation of mitogen-activated protein kinase (MAPK) pathways and retinoic acid-induced neuronal differentiation of SH-SY5Y cells. J. Neurochem. 93: 571-583. (Pubitemid 40617617)
124. Lösel, R., and M. Wehling. 2003. Nongenomic actions of steroid hormones. Nat. Rev. Mol. Cell Biol. 4: 46-56. (Pubitemid 36077256)
125. Piskunov, A., and C. Rochette-Egly. 2012. MSK1 and nuclear receptors signaling. In MSKs. J. S. C. Arthur, editor. Landes Bioscience, Austin.
126. Berry, D. C., H. Jin, A. Majumdar, and N. Noy. 2011. Signaling by vitamin A and retinol-binding protein regulates gene expression to inhibit insulin responses. Proc. Natl. Acad. Sci. USA. 108: 4340-4345.
127. Berry, D. C., and N. Noy. 2012. Signaling by vitamin A and retinol-binding protein in regulation of insulin responses and lipid homeostasis. Biochim. Biophys. Acta. 1821: 168-176.
128. Berry, D. C., S. M. O'Byrne, A. C. Vreeland, W. S. Blaner, and N. Noy. 2012. Cross-talk between signaling and vitamin A transport by the retinol-binding protein receptor STRA6. Mol. Cell. Biol. 32: 3164-3175.
129. Rochette-Egly, C. 2003. Nuclear receptors: integration of multiple signalling pathways through phosphorylation. Cell. Signal. 15: 355-366. (Pubitemid 36254908)
130. Rochette-Egly, C., S. Adam, M. Rossignol, J. M. Egly, and P. Chambon. 1997. Stimulation of RAR alpha activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7. Cell. 90: 97-107. (Pubitemid 28009422)
131. Rochette-Egly, C., M. Oulad-Abdelghani, A. Staub, V. Pfister, I. Scheuer, P. Chambon, and M. P. Gaub. 1995. Phosphorylation of the retinoic acid receptor-alpha by protein kinase A. Mol. Endocrinol. 9: 860-871.
132. Gaillard, E., N. Bruck, Y. Brelivet, G. Bour, S. Lalevée, A. Bauer, O. Poch, D. Moras, and C. Rochette-Egly. 2006. Phosphorylation by PKA potentiates retinoic acid receptor alpha activity by means of increasing interaction with and phosphorylation by cyclin H/cdk7. Proc. Natl. Acad. Sci. USA. 103: 9548-9553. (Pubitemid 43955862)
133. Bastien, J., S. Adam-Stitah, T. Riedl, J. M. Egly, P. Chambon, and C. Rochette-Egly. 2000. TFIIH interacts with the retinoic acid receptor gamma and phosphorylates its AF-1-activating domain through cdk7. J. Biol. Chem. 275: 21896-21904. (Pubitemid 30621761)
134. Samarut, E., and C. Rochette-Egly. 2012. Nuclear retinoic acid receptors: conductors of the retinoic acid symphony during development. Mol. Cell. Endocrinol. 348: 348-360.
135. Bour, G., R. Taneja, and C. Rochette-Egly. 2006. Mouse embryocarcinoma F9 cells and retinoic acid: a model to study the molecular mechanisms of endodermal differentiation. In Nuclear Receptors in Development. R. Taneja, editor. Elsevier Press, San Diego, CA. 211-253. (Pubitemid 44725704)
136. Gudas, L. J., and J. A. Wagner. 2011. Retinoids regulate stem cell differentiation. J. Cell. Physiol. 226: 322-330.
137. Wilson, V., I. Olivera-Martinez, and K. G. Storey. 2009. Stem cells, signals and vertebrate body axis extension. Development. 136: 1591-1604.
138. Bibel, M., J. Richter, E. Lacroix, and Y. A. Barde. 2007. Generation of a defined and uniform population of CNS progenitors and neurons from mouse embryonic stem cells. Nat. Protoc. 2: 1034-1043. (Pubitemid 46901284)
139. Taneja, R., C. Rochette-Egly, J. L. Plassat, L. Penna, M. P. Gaub, and P. Chambon. 1997. Phosphorylation of activation functions AF-1 and AF-2 of RAR alpha and RAR gamma is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment. EMBO J. 16: 6452-6465. (Pubitemid 27483271)
140. Giannì, M., A. Tarrade, E. A. Nigro, E. Garattini, and C. Rochette-Egly. 2003. The AF-1 and AF-2 domains of RAR gamma 2 and RXR alpha cooperate for triggering the transactivation and the degradation of RAR gamma 2/RXR alpha heterodimers. J. Biol. Chem. 278: 34458-34466. (Pubitemid 37553293)
141. Wulf, G., G. Finn, F. Suizu, and K. P. Lu. 2005. Phosphorylation-specific prolyl isomerization: is there an underlying theme? Nat. Cell Biol. 7: 435-441. (Pubitemid 40637396)
142. Vicent, G. P., C. Ballare, A. S. Nacht, J. Clausell, A. Subtil-Rodriguez, I. Quiles, A. Jordan, and M. Beato. 2006. Induction of progesterone target genes requires activation of Erk and Msk kinases and phosphorylation of histone H3. Mol. Cell. 24: 367-381. (Pubitemid 44649285)
143. Vicent, G. P., R. Zaurin, A. S. Nacht, A. Li, J. Font-Mateu, F. Le Dily, M. Vermeulen, M. Mann, and M. Beato. 2009. Two chromatin remodeling activities cooperate during activation of hormone responsive promoters. PLoS Genet. 5: e1000567.
144. Bruck, N., J. Bastien, G. Bour, A. Tarrade, J. L. Plassat, A. Bauer, S. Adam-Stitah, and C. Rochette-Egly. 2005. Phosphorylation of the retinoid x receptor at the omega loop, modulates the expression of retinoic-acid-target genes with a promoter context specificity. Cell. Signal. 17: 1229-1239. (Pubitemid 40982613)
145. Tarrade, A., J. Bastien, N. Bruck, A. Bauer, M. Gianni, and C. Rochette-Egly. 2005. Retinoic acid and arsenic trioxide cooperate for apoptosis through phosphorylated RXR alpha. Oncogene. 24: 2277-2288. (Pubitemid 40546687)
146. Varlakhanova, N., J. B. Hahm, and M. L. Privalsky. 2011. Regulation of SMRT corepressor dimerization and composition by MAP kinase phosphorylation. Mol. Cell. Endocrinol. 332: 180-188.
147. Jonas, B. A., N. Varlakhanova, F. Hayakawa, M. Goodson, and M. L. Privalsky. 2007. Response of SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) and N-CoR (nuclear receptor corepressor) corepressors to mitogen-activated protein kinase kinase kinase cascades is determined by alternative mRNA splicing. Mol. Endocrinol. 21: 1924-1939. (Pubitemid 47173801)
148. Giannì, M., E. Parrella, I. Raska, E. Gaillard, E. A. Nigro, C. Gaudon, E. Garattini, and C. Rochette-Egly. 2006. P38MAPK-dependent phosphorylation and degradation of SRC-3/AIB1 and RARalpha-mediated transcription. EMBO J. 25: 739-751. (Pubitemid 43292436)
149. Ferry, C., S. Gaouar, B. Fischer, M. Boeglin, N. Paul, E. Samarut, A. Piskunov, G. Pankotai-Bodo, L. Brino, and C. Rochette-Egly. 2011. Cullin 3 mediates SRC-3 ubiquitination and degradation to control the retinoic acid response. Proc. Natl. Acad. Sci. USA. 108: 20603-20608.
150. Burns, K. A., and J. P. Vanden Heuvel. 2007. Modulation of PPAR activity via phosphorylation. Biochim. Biophys. Acta. 1771: 952-960. (Pubitemid 47198547)
151. Santos, N. C., and K. H. Kim. 2010. Activity of retinoic acid receptor-alpha is directly regulated at its protein kinase A sites in response to follicle-stimulating hormone signaling. Endocrinology. 151: 2361-2372.
152. Han, Y. H., H. Zhou, J. H. Kim, T. D. Yan, K. H. Lee, H. Wu, F. Lin, N. Lu, J. Liu, J. Z. Zeng, et al. 2009. A unique cytoplasmic localization of retinoic acid receptor-gamma and its regulations. J. Biol. Chem. 284: 18503-18514.
153. Zhu, L., N. C. Santos, and K. H. Kim. 2009. Small ubiquitin-like modifier-2 modification of retinoic acid receptor-alpha regulates its subcellular localization and transcriptional activity. Endocrinology. 150: 5586-5595.
154. Park, U. H., E. J. Kim, and S. J. Um. 2010. A novel cytoplasmic adaptor for retinoic acid receptor (RAR) and thyroid receptor functions as a derepressor of RAR in the absence of retinoic acid. J. Biol. Chem. 285: 34269-34278.
155. Mezaki, Y., N. Yamaguchi, K. Yoshikawa, M. Miura, K. Imai, H. Itoh, and H. Senoo. 2009. Insoluble, speckled cytosolic distribution of retinoic acid receptor alpha protein as a marker of hepatic stellate cell activation in vitro. J. Histochem. Cytochem. 57: 687-699.
156. Chen, N., B. Onisko, and J. L. Napoli. 2008. The nuclear transcription factor RARalpha associates with neuronal RNA granules and suppresses translation. J. Biol. Chem. 283: 20841-20847.
157. Chen, N., and J. L. Napoli. 2008. All-trans-retinoic acid stimulates translation and induces spine formation in hippocampal neurons through a membrane-associated RARalpha. FASEB J. 22: 236-245.
158. Maghsoodi, B., M. M. Poon, C. I. Nam, J. Aoto, P. Ting, and L. Chen. 2008. Retinoic acid regulates RARalpha-mediated control of translation in dendritic RNA granules during homeostatic synaptic plasticity. Proc. Natl. Acad. Sci. USA. 105: 16015-16020.
159. Poon, M. M., and L. Chen. 2008. Retinoic acid-gated sequence-specific translational control by RARalpha. Proc. Natl. Acad. Sci. USA. 105: 20303-20308.
160. Aoto, J., C. I. Nam, M. M. Poon, P. Ting, and L. Chen. 2008. Synaptic signaling by all-trans retinoic acid in homeostatic synaptic plasticity. Neuron. 60: 308-320.
161. Groth, R. D., and R. W. Tsien. 2008. A role for retinoic acid in homeostatic plasticity. Neuron. 60: 192-194.
162. Keriel, A., A. Stary, A. Sarasin, C. Rochette-Egly, and J. M. Egly. 2002. XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARalpha. Cell. 109: 125-135. (Pubitemid 34327522)
163. Blume-Jensen, P., and T. Hunter. 2001. Oncogenic kinase signalling. Nature. 411: 355-365. (Pubitemid 32467045)
164. Slamon, D. J., G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich, and W. L. McGuire. 1987. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 235: 177-182. (Pubitemid 17231334)
165. Tari, A. M., S. J. Lim, M. C. Hung, F. J. Esteva, and G. Lopez- Berestein. 2002. Her2/neu induces all-trans retinoic acid (ATRA) resistance in breast cancer cells. Oncogene. 21: 5224-5232. (Pubitemid 34948134)
166. Srinivas, H., D. M. Juroske, S. Kalyankrishna, D. D. Cody, R. E. Price, X. C. Xu, R. Narayanan, N. L. Weigel, and J. M. Kurie. 2005. c-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor alpha. Mol. Cell. Biol. 25: 1054-1069. (Pubitemid 40165812)
167. Srinivas, H., D. Xia, N. L. Moore, I. P. Uray, H. Kim, L. Ma, N. L. Weigel, P. H. Brown, and J. M. Kurie. 2006. Akt phosphorylates and suppresses the transactivation of retinoic acid receptor alpha. Biochem. J. 395: 653-662.
168. Matsushima-Nishiwaki, R., M. Okuno, S. Adachi, T. Sano, K. Akita, H. Moriwaki, S. L. Friedman, and S. Kojima. 2001. Phosphorylation of retinoid X receptor alpha at serine 260 impairs its metabolism and function in human hepatocellular carcinoma. Cancer Res. 61: 7675-7682. (Pubitemid 32995065)
169. Duong, V., and C. Rochette-Egly. 2011. The molecular physiology of nuclear retinoic acid receptors. From health to disease. Biochim. Biophys. Acta. 1812: 1023-1031.